ALNYLAM PHARMACEUTICALS, INC. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 151.59 | 28,800 | 4,365,792 | 28,800 | |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 151.59 | 17,846 | 2,705,275 | 17,846 | |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.10 | 33,979 | 241,251 | 101,936 | |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 151.59 | 79,998 | 12,126,897 | 79,998 | |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 154.59 | 599 | 92,599 | 206,036 | 206.6 K to 206 K (-0.29 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 153.33 | 431 | 66,085 | 206,635 | 207.1 K to 206.6 K (-0.21 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 152.46 | 1,138 | 173,499 | 207,066 | 208.2 K to 207.1 K (-0.55 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 151.31 | 1,415 | 214,104 | 208,204 | 209.6 K to 208.2 K (-0.68 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 150.22 | 2,054 | 308,552 | 209,619 | 211.7 K to 209.6 K (-0.97 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 148.96 | 1,364 | 203,181 | 211,673 | 213 K to 211.7 K (-0.64 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 148.00 | 4,375 | 647,500 | 213,037 | 217.4 K to 213 K (-2.01 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 146.98 | 6,097 | 896,137 | 217,412 | 223.5 K to 217.4 K (-2.73 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 146.13 | 9,376 | 1,370,115 | 223,509 | 232.9 K to 223.5 K (-4.03 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 145.15 | 6,129 | 889,624 | 232,885 | 239 K to 232.9 K (-2.56 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 143.88 | 1,001 | 144,024 | 239,014 | 240 K to 239 K (-0.42 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.10 | 33,979 | 241,251 | 240,015 | 206 K to 240 K (+16.49 %) |
| Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 119.13 | 8,334 | 992,829 | 25,000 | |
| Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 152.53 | 92 | 14,033 | 17,825 | 17.9 K to 17.8 K (-0.51 %) |
| Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 156.00 | 1,618 | 252,408 | 17,917 | 19.5 K to 17.9 K (-8.28 %) |
| Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 5,416 | 0 | 19,535 | 14.1 K to 19.5 K (+38.36 %) |